Last reviewed · How we verify

NCT05818813: RDN flow

The Long-term Safety and Effect of Renal Denervation

Terminated Last updated 27 March 2026
What this trial tests

trial testing Renal denervation in Hypertension in 9 participants. Terminated before completion.

Timeline
27 April 2021
Primary endpoint
16 April 2024
16 April 2024

Quick facts

Lead sponsorImperial College Healthcare NHS Trust
StatusTerminated
Study typeOBSERVATIONAL
Enrollment9
Start date27 April 2021
Primary completion16 April 2024
Estimated completion16 April 2024
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Imperial College Healthcare NHS Trust

Who can join

18 and older, any sex, with Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to learn about the effects of renal denervation in patients with resistant hypertension. The main question it aims to answer is: What are the long term effects of renal denervation on blood pressure and flow within the arteries? Participants will undergo an assessment of their blood pressure, echocardiogram and invasive measurements of blood pressure and flow in the aorta and renal arteries before undergoing the renal denervation procedure. 6 months later these assessments will be repeated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Renal denervation

Trials testing the same drug.

Other recruiting trials for Hypertension

Currently open trials in the same condition.

Other Imperial College Healthcare NHS Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05818813.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing